Sona Nanotech's Targeted Hyperthermia Therapy To Be Presented at the International 19th Canadian Melanoma Conference Technology InvestingFeb 12, 2025 03:24AM PST
Sona Nanotech's THT Cancer Therapy Preclinical Efficacy Studies Published In Peer-Reviewed Scientific Journal Technology InvestingJan 13, 2025 04:22AM PST
Sona Nanotech's THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study Technology InvestingDec 11, 2024 04:01AM PST
Sona Nanotech to Showcase Its THT Cancer Therapy at NCL 20th Anniversary Symposium and Provides Corporate Update Technology InvestingNov 7, 2024 03:15AM PST
Sona Nanotech Issued Patent and Appoints New Board Member Technology InvestingOct 21, 2024 11:32AM PST
Sona Nanotech Closes Private Placement Financing to Raise $1,643,750 in Gross Proceeds Technology InvestingSep 24, 2024 03:47AM PST
Sona Nanotech Closes Private Placement Financing to Raise $1,500,000 in Gross Proceeds and Announces Additional Financing Technology InvestingSep 5, 2024 03:25AM PST
Sona Nanotech (CSE:SONA) Sona Nanotech to Arrange Private Placement Financing Technology InvestingJul 31, 2024 03:22AM PST
Sona Nanotech (CSE:SONA) Sona's Cancer Therapy Triggers Abscopal Effect, Eliminating Distant Tumors In Preclinical Melanoma Study Technology InvestingJun 26, 2024 04:54AM PST